Peptide Therapy · Episode 1

Peptide Therapy: What You Need to Know Before You Inject

Before starting a peptide, understand the clinical goal, the evidence, the product source, the dose, and the monitoring plan.

Dr. Kish Carlton · 9 min read

Peptide therapy has become one of the most discussed areas of health and wellness. Social media is filled with claims about reversing aging, healing injuries, improving body composition, sharpening memory, and extending life.

Some peptides have legitimate, well-established medical uses. Others have limited human evidence, uncertain product quality, or are sold through channels that provide little clinical accountability.

Before injecting any peptide, it is important to understand that the word “peptide” tells you very little about whether a particular treatment is safe, effective, or appropriate for you.

What Is a Peptide?

Peptides are short chains of amino acids. Many naturally occurring peptides function as signaling molecules, allowing cells and organs to communicate with one another.

A peptide may influence appetite, hormone signaling, inflammation, tissue repair, glucose regulation, or other biological processes. However, producing a biological signal does not guarantee that a treatment will produce a meaningful clinical benefit.

The body must also have the necessary nutrients, metabolic capacity, and physiological resources to carry out that signal. Using a peptide while ignoring foundational health problems can be like putting high-octane gasoline into a car with no oil: you may push the system harder without addressing what it actually needs.

Not All Peptide Products Are the Same

Peptide-based products generally fall into several very different categories.

FDA-Approved Peptide Medications

Some peptide-based medications have undergone formal evaluation for manufacturing quality, dosing, safety, and effectiveness. Examples include insulin, certain GLP-1 medications, and teriparatide.

FDA approval applies to a specific medication for particular indications. It does not mean that every product described as a peptide has been evaluated or approved.

Compounded Peptide Medications

A licensed compounding pharmacy may prepare a medication for an individual patient when a commercially available product cannot appropriately meet that patient’s needs.

However, compounded medications are not FDA-approved. The FDA does not verify their safety, effectiveness, or quality before they are marketed. Compounding can fill an important medical need, but the pharmacy, prescription, formulation, testing, and chain of custody all matter. Learn more from the FDA about compounded medications:

“Research Use Only” Products

Products purchased online and labeled “research use only” belong in an entirely different risk category. Such labeling does not establish that a product is sterile, accurately dosed, appropriately manufactured, or suitable for human treatment.

The FDA has warned sellers that placing a “research use only” disclaimer on products promoted for human use does not make those products legally or medically appropriate. Read an example of an FDA warning involving research peptides:

Start With the Problem—not the Product

Before considering a peptide, define the clinical problem you are trying to solve.

That evaluation may include:

• Medical history and current medications
• Sleep and nutrition
• Hormonal and metabolic health
• Kidney and liver function
• Cardiovascular risk
• Baseline laboratory testing
• Symptoms and measurable treatment goals

If the evaluation reveals anemia, thyroid disease, insulin resistance, sleep apnea, medication effects, or a meaningful nutrient deficiency, correcting the underlying problem may accomplish more than adding another peptide.

Good medical care begins with a diagnosis and a clinical objective—not with a product looking for a reason to be used.

Product Quality and Chain of Custody Matter

With any injectable product, important questions include:

• Does the vial contain what the label claims?
• Is the concentration accurate?
• Was it prepared under appropriate conditions?
• Is it sterile?
• Could it contain endotoxins, residual solvents, or degradation products?
• Was it stored and transported correctly?
• Is the product traceable to an accountable pharmacy or manufacturer?

A certificate of analysis can be helpful, but it is not automatically proof that the vial in your possession was produced, tested, stored, and shipped appropriately.

If something goes wrong, there should be a licensed pharmacy, prescribing clinician, and accountable medical system standing behind the treatment.

Dosing and Measurement Require Precision

Injectable peptides can create confusion because several measurements may appear in the same treatment plan.

For example:

• A vial may be labeled in milligrams.
• The prescribed dose may be expressed in micrograms.
• The syringe measures liquid volume in units.
• The final concentration depends on how the product was reconstituted.

These measurements are not interchangeable. A misunderstanding about concentration or a misplaced decimal point can produce a significant dosing error.

Each patient should receive the exact concentration, prescribed dose, injection volume, storage instructions, and discard date in writing. Dosing should never depend on a social-media screenshot or an unverified online calculator.

Storage and Injection Technique Matter Too

Product quality can be lost after a medication leaves the pharmacy. Follow the pharmacy’s instructions regarding refrigeration, protection from light, reconstitution, travel, and the beyond-use date.

Safe handling also includes:

• Clean hands
• A new sterile syringe and needle for every injection
• Proper disposal of used sharps
• Never sharing injection supplies
• Using the injection technique taught by the clinical team

Increasing redness, warmth, swelling, drainage, fever, or systemic symptoms should prompt medical evaluation rather than simply continuing injections.

Every Treatment Needs a Monitoring Plan

A responsible treatment plan includes a clear method for determining whether the therapy is helping.

Monitoring might include:

• Symptoms and functional improvement
• Body composition
• Blood pressure
• Glucose control
• Hormone levels
• IGF-1
• Blood counts
• Metabolic testing
• Other targeted measurements

The goal is not to order every test imaginable. The goal is to measure what should reasonably change and to establish criteria for continuing, adjusting, or stopping treatment.

Ideally, one major variable is changed at a time. Otherwise, benefits become anecdotes, adverse effects become difficult to trace, and nobody can confidently determine what produced the result.

Watch for These Marketing Red Flags

Be cautious when a person or company:

• Promises a cure or guaranteed result
• Recommends the same treatment and dose to everyone
• Immediately sells a large stack of compounds
• Does not review your medical history or medications
• Provides injections without baseline testing or monitoring
• Sells products without a prescription or pharmacy label
• Uses “not for human consumption” language while providing injection instructions
• Relies almost entirely on testimonials instead of clinical evidence

A personal success story may be sincere, but it is not the same as reliable evidence.

Five Questions to Ask Before Starting Peptide Therapy

Before beginning treatment, you should be able to answer these questions:

1. What specific problem are we treating?
2. Why was this particular compound selected?
3. What level of human evidence supports its use?
4. Who manufactured or compounded the product, and how can its identity and handling be verified?
5. What will we monitor, and what findings would cause us to reduce the dose, change treatment, or stop?

If these questions cannot be answered clearly without falling back on marketing language, that is a reason to pause.

The Bottom Line

Peptides are not magic, and they are not automatically dangerous. They are tools.

The outcome depends on the evidence, the specific product, the patient, the dose, and the clinical system surrounding its use.

Responsible peptide therapy should look less like purchasing a supplement and more like receiving medical care. It should include a clinical assessment, discussion of expected benefits and uncertainties, informed consent, an appropriate prescription when required, a traceable pharmacy source, written dosing instructions, and a follow-up plan.

At Mind Body Spirit Medicine, treatment decisions begin with the patient—not the product. Our goal is to understand the complete clinical picture and determine whether a proposed therapy is appropriate, measurable, and supported by a responsible plan.